Our Pipeline of Human Clinical Trials

IBAL Clinical Trials

We are committed to discover new ways to help people.

February 15, 2021

Ion Gel ZCM-25® Clinical Phase 2 Human Dosing & Efficacy Study

Public Relations
Ion Gel ZCM-25® Clinical Phase 2 Human Dosing & Efficacy Study with COFEPRIS Approval The Ion Gel ZCM-25® Clinical Phase […]
October 5, 2020

Ion Gel ZCM-25® Clinical Phase 1 Human Safety Study

Public Relations
Bioemagno’s Clinical Pharmacology Unit recently completed a rigorous Phase 1 human safety study evaluating Ion Gel ZCM-25®, a Class II […]
June 15, 2014

ION-ZC1 – Topical Skin Irritation on Humans

Public Relations
Verified Topical Skin Irritation Study Confirms ION-ZC1 Cream Is Safe for Human Use   This topical skin irritation study evaluated the […]

Learn about our most recent milestones

NEWS ROOM
selectmagnifiercrossmenu-circle